Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday’s regular session. The current volume of 532.2K…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 8.5% to $1.28 during Friday’s after-market session. The company’s market…
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday’s Mid-Day Session
Gainers
Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24.
Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Vapotherm (NYSE:VAPO) shares rose 44.2% to $1.28 during Thursday’s regular session. As of 12:30 EST, this security…
Nasdaq Turns Lower; Dow Tumbles Over 300 Points
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 300 points on Thursday.
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session.
Important Biotech Catalysts For September 13, 2022 – End Of The Day Summary
Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety…